Google Maps

NCT07730047

Overview

NCT ID: NCT07730047
Lead Sponsor: Shaimaa Ali MohammedOTHER
Official Title: Neutrophil-to-Lymphocyte Ratio (NLR), Eosinophil-to-Lymphocyte Ratio (ELR), and Systemic Immune-Inflammation (SII) Index as Biomarkers of Asthma Control
Brief Summary: This is Case control study aims to study Neutrophil-to-Lymphocyte Ratio (NLR), Eosinophil-to-Lymphocyte Ratio (ELR), and Systemic Immune Inflammation (SII) Index as Biomarkers of Asthma Controlin adult patients with bronchial asthma.

This study will investigate the association between these inflammatory indices and the level of asthma control to assess their potential value as simple ,readily available and cost -effective biomarkers in clinical practice.
Conditions: Asthma Control
Interventions

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: Yes
Eligibility Criteria: Inclusion Criteria:

Adult patients aged > 18 years.

Confirmed diagnosis of bronchial asthma according to Global Initiative for Asthma (GINA) guidelines.

Patients who provided informed consent to participate in the study.

Exclusion Criteria:

Patients with chronic respiratory diseases other than asthma.

Acute respiratory infection within the previous 4 weeks.

Patients with hematological disorders, malignancies, autoimmune diseases, or systemic inflammatory conditions that might affect blood cell counts.

Patients taking systemic steroids, experiencing acute asthma attack (because infection may affect neutrophil level).

Pregnant women.

Central Contacts: Shaimaa A Mohammed, MDContact
drshimaalimohammed@gmail.com00201016599093